SARS-CoV-2 B.1. 351 Variant Nucleic Acid Detection Kit (Fluorescence RT-PCR) uses fluorescence quantitative PCR method with MGB probes designed specifically for detecting single nucleotide mutations targeting N501Y, K417N and other mutant sites on the S protein gene of B.1.351 mutant strain to optimize the reaction system and procedure which ensure the SARS-CoV-2 had high specificity with the wild strain. This kit also has the characteristics of high specificity and high sensitivity, which can be timely diagnosed in the early stage of virus infection, and has guiding significance for diagnosis and treatment.
Product features
Accurate detection:it can be accurately detected even when the nucleic acid content of the mutant strains accounts for only 5% of the wild strains.
Simple operation: One-step RT-PCR less than 1 hour, amplification and detection can be completed in closed tube to prevent aerosol contamination.
Strong applicability: suitable for human nasopharyngeal swab.
High sensitivity: Three different batches of reagents were tested with a sensitivity of up to 500 copies/ml.
Resist disturbance: The interfering substances had no effect on the test results.
Strong specificity: no cross reaction with similar viruses such as influenza A H1N1 virus etc.
